15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 19 firms covering Amgen Inc, 5 rate it Buy or better, 13 sit at Hold, and 1 rate it Sell or worse, a hold consensus. Targets span $303.00 to $427.00, a moderate spread. The average target of $360.25 sits 8% below the current $393.10. The rating mix has stayed broadly stable, with Buy-side ratings easing from 6 to 5 over recent months. On the fundamentals, the Street sees revenue growth near 3% this year and 3% next, consensus EPS building from about $5.74 next quarter toward $23.46 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS19 ratings
Hold
Strong Buy00%
Buy526%
Hold1368%
Sell15%
Strong Sell00%
Based on 19 analysts giving stock ratings to Amgen Inc.
As of Jul, 5 of 19 firms rate AMGN a Buy (13 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
AMGN EPS & revenue forecast
EPS · NEXT QUARTER
$5.74
Range $5.43 – $6.14 · 23 analysts · +2% YoY
Next period, 23 analysts expect Amgen Inc to earn $5.74 a share (range $5.43 – $6.14), versus $5.64 a year earlier. Full-year consensus is $22.34, growing to $23.46 the year after.
REVENUE · NEXT QUARTER
$9.7B
Range $9.5B – $10.1B · 23 analysts · +1% YoY
Revenue is expected to reach $9.7B (range $9.5B – $10.1B), +1.0% year-over-year. Full-year consensus is $37.8B, rising to $38.7B next year.
Top analysts covering Amgen Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AMGN.
#1
David Amsellem
Piper Sandler · Rank #95
Buy
$427.00+8.6% to target
Overall win rate
50%
+ Follow
#2
TA
Tazeen Ahmad
B of A Securities · Rank #275
Sell
$312.00-20.6% to target
Overall win rate
41%
+ Follow
#3
Jay Olson
Oppenheimer · Rank #302
Buy
$400.00+1.8% to target
Overall win rate
32%
+ Follow
#4
Vamil Divan
Guggenheim
Hold
$343.00-12.7% to target
Coverage
—
+ Follow
#5
Terence Flynn
Morgan Stanley
Hold
$333.00-15.3% to target
Coverage
—
+ Follow
AMGN stock forecast FAQ
What is AMGN's average 12-month price target?+
The 16 analysts with a live target average $360.25 for Amgen Inc over the next 12 months, ranging from a $427.00 high to a $303.00 low.
Is AMGN stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 19 analyst ratings, 5 are Buy or Strong Buy, 13 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for AMGN?+
The Street-high target is $427.00 (Piper Sandler), and the Street-low is $303.00 (Mizuho). The average of all 16 active targets is $360.25.
How many Wall Street analysts cover AMGN?+
19 analysts have an active rating on Amgen Inc, and 16 firms carry a live 12-month price target.
Who is the most accurate analyst covering AMGN?+
Among analysts who currently cover AMGN, David Amsellem of Piper Sandler has the strongest overall Quantellect track record (Rank #95). Their current call is Buy with a $427.00 target.
What is Amgen Inc's projected EPS for next quarter?+
The consensus estimate is $5.74 per share (range $5.43 – $6.14) across 23 analysts. Full-year EPS is projected at $22.34, rising to $23.46 the following year.
How much revenue is Amgen Inc expected to report next quarter?+
Consensus revenue is $9.7B (range $9.5B – $10.1B). Full-year revenue is projected at $37.8B, growing to $38.7B next year.
Have analysts been upgrading or downgrading AMGN lately?+
As of Jul, 5 of 19 firms rate AMGN a Buy (13 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AMGN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
